← Eichor
Condition: Transplantation Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Transplantation Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administ
Phase 1/Phase 2 · 8 location(s) · SNIPR Biome Aps. · NCT06938867MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
NA · 1 location(s) · Medical College of Wisconsin · NCT05794880Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT07347769Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT
Phase N/A · 1 location(s) · Mahidol University · NCT06700876Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)
Phase N/A · 1 location(s) · University Hospital, Clermont-Ferrand · NCT06986980FMT in Initial CDI
NA · 1 location(s) · Turku University Hospital · NCT05257538The Application of Infrared Thermography in the Prediction of Skin Healing in Surgery
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07524062Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06782880Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Phase 1 · 3 location(s) · Children's National Research Institute · NCT04691622Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06498310Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infec
Phase 1/Phase 2 · 1 location(s) · LucasBio · NCT07670468Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Phase 2 · 1 location(s) · Loyola University · NCT05554068Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Foll
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05470491Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections
Phase N/A · 1 location(s) · The Second Hospital of Nanjing Medical University · NCT03895593A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patien
Phase 3 · 29 location(s) · Children's Oncology Group · NCT05711667A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
Phase N/A · 25 location(s) · Takeda · NCT06243731Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders
Phase 2 · 2 location(s) · Fudan University · NCT07381738Inspiratory Work of Breathing Before and After Extubation
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT07017608Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit fo
Phase 4 · 1 location(s) · University Hospital, Strasbourg, France · NCT06881927A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
Phase 3 · 8 location(s) · GC Biopharma Corp · NCT05686759Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bact
Phase 1/Phase 2 · 1 location(s) · University of Rijeka · NCT07106580Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
NA · 1 location(s) · Krunal Patel · NCT03562741Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Chil
NA · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT07693881The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in
Phase 4 · 1 location(s) · National Taiwan University Hospital · NCT05588492Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
Phase 2/Phase 3 · 1 location(s) · Hospital Israelita Albert Einstein · NCT03818334Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients
Phase 1/Phase 2 · 1 location(s) · University of California, San Diego · NCT06409819Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03314974A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
Phase 3 · 81 location(s) · SymBio Pharmaceuticals · NCT07387367Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy
Phase 1/Phase 2 · 1 location(s) · Tel-Aviv Sourasky Medical Center · NCT05329636Effect of Preoperative Vitamin D Supplementation in Liver Transplant Recipients With Vitamin D Deficiency on Post Transp
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT06736093
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.